News

Xarelto claims Updates: Johnson & Johnson gave kickback of $49.3 million to doctors

xarelto-1106
Written by admin

Johnson & Johnson is an American multinational medical devices pharmaceutical which was founded in 1886. The company includes some 250 subsidiary companies with operations in 60 countries and products sold in over 175 countries. As per a survey Johnson & Johnson had worldwide sales of $70.1 billion in 2015. Xarelto is also one of the highest selling products of the healthcare giant Johnson & Johnson. Xarelto is a blood thinner manufactured by Bayer and is marketed by Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals. Xarelto was initially approved in 2011 and is one of the most recent blood thinners on the market. It was the first and only oral anticoagulant approved to treat DVT and PE without the need for injections or routine blood monitoring. The patients took Xarelto to treat them from atrial fibrillation (irregular heart rhythm), hypertension, or other valvular heart conditions.

As per a report by Dollars For Docs Database that publishes data regarding physician payments from drug companies, Johnson & Johnson (J&J) and its subsidiary, Janssen Pharmaceuticals, paid out a total of $49.3 million as a kickback to doctors in the form of compensation for travel, consulting fees, compensation for meals, and gifts. J&J paid out $20.9 million related to its diabetes medication Invokana and for its anticoagulant drug Xarelto the payable amount was approximately $28.4 million. A kickback is a form of negotiated bribery which is illegal and not allowed and medical guidelines do not allow such practice by manufacturers to pay doctors for prescribing certain medications for their benefits. Xarelto associated with severe adverse events include internal bleeding, fatal brain and stomach bleeds. There is allegedly no antidote to stop uncontrolled bleeding, which can lead Xarelto to cause someone to bleed to death.

As per a report released by the the Louisiana court, lawsuits against the blockbuster blood-thinning drug manufacturers, Xarelto have now reached 15000 across the country. As of December 15 of 2016 over 14,465 lawsuits are in process regarding Xarelto and according to the report all the Xarelto lawsuits will be consolidated for multidistrict litigation (MDL No. 2592) in Louisiana. The plaintiffs allege that the manufacturers Bayer and Janssen knew or should have known of the risks associated with the drug. Bayer and Janssen Pharmaceuticals failed to adequately warn doctors as well as patients about the adverse effects cause by the life threatening drug Xarelto and the manufacturers were reckless in releasing the drug to market without a corresponding antidote, which can lead Xarelto to cause someone to bleed to death. Despite of giving kickback to the doctors the manufactures have to break their silence and reveal the risk linked with the drug.

If you or your love ones are facing fatal complication due to real brad of Xarelto can take a legal action against the company. He/she can claim for reimbursement money against complication or loss within limited period of time. We look forward to fighting for the rights of our clients. We have an experience attorneys group who evaluate your case free of cost unless we win the case for you. Contact Drugsclaim.com for free case review.

 

About the author

admin

Leave a Comment